The nitrovinyl moiety determines the cyto- and genotoxic profiles of β-nitrostyrene derivatives: evidence from in silico and in vitro evaluation - Top-Institutions - MDSpire

The nitrovinyl moiety determines the cyto- and genotoxic profiles of β-nitrostyrene derivatives: evidence from in silico and in vitro evaluation

  • By

  • Jan Sündermann

  • Stella Marie Reamon-Buettner

  • Sabrina Wilde

  • Annette Bitsch

  • Christina Ziemann

  • March 31, 2026

  • 0 min

Share

Top Institutions in General Medicine

Brief introduction explaining scope and methodology.

  • #1

    National Institute of Environmental Health Sciences (NIEHS)
    National Institute of Environmental Health Sciences (NIEHS)

    Research Triangle Park, NC

    Key Differentiators

    • Toxicology
    • Environmental Health
    • Molecular Pharmacology

  • #2

    Harvard T.H. Chan School of Public Health
    Harvard T.H. Chan School of Public Health

    Boston, MA

    Key Differentiators

    • Toxicology
    • Environmental Health Sciences
    • Pharmacology

  • #3

    Johns Hopkins Bloomberg School of Public Health
    Johns Hopkins Bloomberg School of Public Health

    Baltimore, MD

    Key Differentiators

    • Toxicology
    • Molecular Epidemiology
    • Pharmacology

  • #4

    University of California, San Francisco (UCSF) School of Medicine
    University of California, San Francisco (UCSF) School of Medicine

    San Francisco, CA

    Key Differentiators

    • Pharmacology
    • Toxicology
    • Cancer Biology

Original Source(s)

The nitrovinyl moiety determines the cyto- and genotoxic profiles of β-nitrostyrene derivatives: evidence from in silico and in vitro evaluation

  • by Jan Sündermann, Stella Marie Reamon-Buettner, Sabrina Wilde, Annette Bitsch, Christina Ziemann

  • March 31, 2026

Related Content

Cancer patients’ insights and experience of palliative and supportive care in the UAE: a qualitative study

MicroRNAs in cancer: biogenesis, biomarkers and therapeutic strategies

Barriers and Variations in Cancer Diagnosis: A Cross-Sectional Analysis of Patient Journeys and Healthcare Provider Timelines in Public Health Systems of Chile, Colombia, and Ecuador